What is Wedbush’s Estimate for KNSA Q1 Earnings?
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) – Stock analysts at Wedbush issued their Q1 2026 earnings per share estimates for shares of Kiniksa Pharmaceuticals in a research note issued to investors on Tuesday, April 29th. Wedbush analyst D. Nierengarten expects that the company will post earnings per share of $0.31 for the quarter. Wedbush […]
